Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Omnicell (OMCL)

Omnicell Q3 revenue falls 1% to $308 million; raises full-year profit guidance

Mixed Impact 4 of 5 earnings

Omnicell reported third-quarter 2026 revenue of $308 million, down $3 million, or 1%, from a year earlier, while GAAP net income rose to $11 million, or $0.24 per diluted share, from $5 million, or $0.12. The company raised its full-year 2026 non-GAAP EBITDA and non-GAAP earnings per share guidance, so profit expectations improved even as revenue slipped.

Key points

  • Q3 2026 non-GAAP net income was $27 million, or $0.58 per diluted share, versus $24 million, or $0.51, in Q3 2025.
  • Full-year 2026 non-GAAP EBITDA guidance was raised to $187 million-$193 million; non-GAAP EPS guidance was raised to $2.48-$2.56.
  • Full-year 2026 total revenue guidance was tightened to $1.225 billion-$1.231 billion.
  • As of September 30, 2026, cash and cash equivalents were $315 million and the company had $350 million of undrawn revolving credit availability.

The filing

CompanyOmnicell (OMCL)
Form8-K, current report
Filed with the SECOct 29, 2026, 6:35 AM ET
Accession number0000926326-26-000024

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.